RESIGNATION TO: lnMed Pharmaceuticals Inc. (the "Company") Attention: Andrew Hull, Chairman Dear Andrew, I hereby tender my resignation for approval by the Company's board of directors. Further, I hereby resign as a memb
Friday, February 14, 2025 1 min read
Key Takeaway: Janet Grove has tendered her resignation to lnMed Pharmaceuticals Inc., effective immediately. Along with stepping down from her position as a board member, she also resigns from the Compensation Committee and Governance and Nomination Committee. This resignation may lead to concerns regarding the company's internal leadership stability.
Market Sentiment Analysis
CONCERNS & RISKS
The resignation may indicate instability within the company's leadership.
The immediate departure of a key executive could disrupt ongoing projects.
Full Press Release Details
I hereby tender my resignation for approval by
the Company's board of directors.
Further, I hereby resign as a member of the Company's
Compensation Committee and Governance and Nomination Committee, effective immediately.
DATED: December 18, 2024
/s/ Janet Grove
JANET GROVE
Frequently Asked Questions
Who is resigning from the company?
Janet Grove is resigning from her position.
When did the resignation take place?
The resignation is effective immediately as of December 18, 2024.
What committees did Janet Grove resign from?
Janet Grove resigned from the Compensation and Governance Committees.
To whom is the resignation submitted?
The resignation is submitted to the Company's board of directors.